UY32515A - Nuevos derivados anticancerosos de nicotinamida, su preparación y su aplicación terapéutica - Google Patents

Nuevos derivados anticancerosos de nicotinamida, su preparación y su aplicación terapéutica

Info

Publication number
UY32515A
UY32515A UY0001032515A UY32515A UY32515A UY 32515 A UY32515 A UY 32515A UY 0001032515 A UY0001032515 A UY 0001032515A UY 32515 A UY32515 A UY 32515A UY 32515 A UY32515 A UY 32515A
Authority
UY
Uruguay
Prior art keywords
nicotinamide
preparation
therapeutic application
new anti
target derivatives
Prior art date
Application number
UY0001032515A
Other languages
English (en)
Inventor
Monsif Bouaboula
Romain Combet
Sandrine Hilairet
Samir Jegham
Arigon Jerome
Bernhart Claude
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of UY32515A publication Critical patent/UY32515A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere a derivados de nicotinamida que pueden ser utilizados como anticancerosos
UY0001032515A 2009-03-24 2010-03-24 Nuevos derivados anticancerosos de nicotinamida, su preparación y su aplicación terapéutica UY32515A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0901367A FR2943675A1 (fr) 2009-03-24 2009-03-24 Composes anticancereux, leur preparation et leur application en therapeutique
FR0901589A FR2943671B1 (fr) 2009-03-24 2009-03-31 Composes anticancereux,leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
UY32515A true UY32515A (es) 2010-10-29

Family

ID=41137868

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032515A UY32515A (es) 2009-03-24 2010-03-24 Nuevos derivados anticancerosos de nicotinamida, su preparación y su aplicación terapéutica

Country Status (8)

Country Link
US (1) US20120053209A1 (es)
EP (1) EP2411364A1 (es)
JP (1) JP2012521395A (es)
AR (1) AR075922A1 (es)
FR (2) FR2943675A1 (es)
TW (1) TW201038268A (es)
UY (1) UY32515A (es)
WO (1) WO2010109115A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2810038A1 (en) 2010-09-03 2012-03-08 Forma Tm, Llc Novel compounds and compositions for the inhibition of nampt
BR112013028281A2 (pt) 2011-05-04 2017-01-10 Forma Tm Llc compostos e composições para inibição de nampt

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19756261A1 (de) * 1997-12-17 1999-07-01 Klinge Co Chem Pharm Fab Neue arylsubstituierte Pyridylalkan-, alken- und alkincarbonsäureamide
MY153569A (en) * 1998-01-20 2015-02-27 Mitsubishi Tanabe Pharma Corp Inhibitors of ?4 mediated cell adhesion
FR2921657A1 (fr) * 2007-09-28 2009-04-03 Sanofi Aventis Sa Derives de nicotinamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
WO2010109115A9 (fr) 2011-12-15
AR075922A1 (es) 2011-05-04
EP2411364A1 (fr) 2012-02-01
US20120053209A1 (en) 2012-03-01
JP2012521395A (ja) 2012-09-13
TW201038268A (en) 2010-11-01
FR2943675A1 (fr) 2010-10-01
WO2010109115A1 (fr) 2010-09-30
FR2943671B1 (fr) 2011-05-06
FR2943671A1 (fr) 2010-10-01

Similar Documents

Publication Publication Date Title
CY1123958T1 (el) Μεθοδος παρασκευης παραγωγων και ενδιαμεσων καρβαμοϋλπυριδονης
CR20130001A (es) Derivados de indolizina, su procedimiento de preparación y su aplicación en terapéutica
HN2012000437A (es) Nuevos agentes anticancer y la preparacion de dichos agentes
ECSP14027269A (es) Picolinamidas macrocíclicas como fungicidas
UA108101C2 (xx) Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
UY33735A (es) Compuestos antivirales
GT201400147A (es) Pirimidinas y triazinas fusionadas sustituidas y su uso
NI201000005A (es) Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico.
CU23874B1 (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y su uso
NI200800207A (es) Agentes citotóxicos que comprenden nuevos derivados de tomaimicina
CO7350620A2 (es) Nuevos derivados de piridina
GT201000023A (es) Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met.
NI201100011A (es) Derivados de piridino - piridinonas, su preparación y su aplicación en terapéutica.
UA86731C2 (ru) Делимая галеновая форма модифицированного высвобождения активного ингредиента
UY34314A (es) Derivados de anilina, su preparación y su aplicación terapéutica.
GT201200154A (es) Derivados de piridino-piridinonas, su preparación y su aplicación en terapéutica
DOP2009000264A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica
UA107671C2 (en) N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
NI201100149A (es) Derivados de tiadiazoles y oxadiazoles, su preparación y su aplicación en terapia.
TR201908180T4 (tr) N1-asil- 5-floropirimidinon deriveleri.
HN2010001537A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
BR112013018287A2 (pt) derivados monoterpenos de chalcona ou de diidrochalcona e sua utilização como agentes de despigmentação
CR20110701A (es) Derivados de pirazoles, su preparacion y su aplicacion terapeutica.
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
UY34807A (es) Derivados monocíclicos de heteroarilcicloalquil- diamina

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150615